Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver Enzymes-Reference-Cited by-同舟云学术

Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver Enzymes

Published:2020-10 Issue:4 Volume:72 Page:1242-1252
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Natarajan Yamini¹^ORCID,Kramer Jennifer R.²^ORCID,Yu Xian²,Li Liang³,Thrift Aaron P.¹⁴⁵,El‐Serag Hashem B.¹²⁴⁶,Kanwal Fasiha¹²⁴⁶

Affiliation:

1. Section of Gastroenterology and Hepatology Michael E. DeBakey VA Medical Center and Baylor College of Medicine Houston TX

2. Clinical Epidemiology and Comparative Effectiveness Program Section of Health Services Research (IQuESt) Michael E. DeBakey VA Medical Center and Baylor College of Medicine Houston TX

3. Department of Biostatistics University of Texas MD Anderson Cancer Center Houston TX

4. Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine Houston TX

5. Section of Epidemiology and Population Sciences Baylor College of Medicine Houston TX

6. Texas Medical Center Digestive Disease Center Houston TX

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31157

Reference35 articles.

1. Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

2. High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study

3. Population-Based Trends in Prevalence of Nonalcoholic Fatty Liver Disease in US Adults With Type 2 Diabetes

4. Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C

5. Final results of a long-term, clinical follow-up in fatty liver patients

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highly sensitive near-infrared fluorescent probe for monitoring peroxynitrite in nonalcoholic fatty liver disease: Toward early diagnosis and therapeutic evaluation;Talanta;2025-01

2. Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies;Journal of the Canadian Association of Gastroenterology;2024-08-09

3. Modifiable Risk Factors for Hepatocellular Carcinoma in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-Analysis;The American Journal of Medicine;2024-07

4. Identification of hepatic steatosis among persons with and without HIV using natural language processing;Hepatology Communications;2024-06-19

5. Non-invasive biomarkers prognostic of decompensation events in NASH cirrhosis: a systematic literature review;Journal of Molecular Medicine;2024-05-16